[1]
|
Vardiman, J.W., Thiele, J., Arber, D.A., Brunning, R.D., Borowitz, M.J., Porwit, A., Harris, N.L., Le Beau, M.M., Hellstrom-Lindberg, E., Tefferi, A. and Bloomfield, C.D. (2009) The 2008 Revision of the World Health Organization (WHO) Classification of Myeloid Neoplasms and Acute Leukemia: Rationale and Important Changes. Blood, 114, 937-951. http://dx.doi.org/10.1182/blood-2009-03-209262
|
[2]
|
National Cancer Institute (2013) National Cancer Institute SEER Cancer Statistics Review 1975-2010. National Cancer Institute, 1992-2010.
|
[3]
|
Dennis, E.A. (2009) Lipidomics Joins the Omics Evolution. Proceedings of the National Academy of Sciences of the United States of America, 106, 2089-2090. http://dx.doi.org/10.1073/pnas.0812636106
|
[4]
|
Han, X. and Gross, R.W. (2005) Shotgun Lipidomics: Electrospray Ionization Mass Spectrometric Analysis and Quantitation of Cellular Lipidomes Directly from Crude Extracts of Biological Samples. Mass Spectrometry Reviews, 24, 367-412. http://dx.doi.org/10.1002/mas.20023
|
[5]
|
Wenk, M.R. (2010) Lipidomics: New Tools and Applications. Cell, 143, 888-895. http://dx.doi.org/10.1016/j.cell.2010.11.033
|
[6]
|
Roberts, L.D., McCombie, G., Titman, C.M. and Griffin, J.L. (2008) A Matter of Fat: An Introduction to Lipidomic Profiling Methods. Journal of Chromatography B, 871, 174-181. http://dx.doi.org/10.1016/j.jchromb.2008.04.002
|
[7]
|
Wymann, M.P. and Schneiter, R. (2008) Lipid Signalling in Disease. Nature Reviews Molecular Cell Biology, 9, 162-176. http://dx.doi.org/10.1038/nrm2335
|
[8]
|
Murphy, R.C., Raetz, C.R.H., Reynolds, C.M. and Barkley, R.M. (2005) Mass Spectrometry Advances in Lipidomica: Collision-Induced Decomposition of Kdo2-Lipid A. Prostaglandins & Other Lipid Mediators, 77, 131-140. http://dx.doi.org/10.1016/j.prostaglandins.2004.09.004
|
[9]
|
Gross, R.W. and Han, X. (2011) Lipidomics at the Interface of Structure and Function in Systems Biology. Chemistry & Biology, 18, 284-291. http://dx.doi.org/10.1016/j.chembiol.2011.01.014
|
[10]
|
Karpova, M.A., Moshkovskii, S.A., Toropygin, I.Y. and Archakov, A.I. (2010) Cancer-Specific MALDI-TOF Profiles of Blood Serum and Plasma: Biological Meaning and Perspectives. Journal of Proteomics, 73, 537-551. http://dx.doi.org/10.1016/j.jprot.2009.09.011
|
[11]
|
Rübsaamen, K. (2010) Lipidomic Analysis of Circulating Human Blood Cells. Doctoral Thesis, University of Regensburg, Regensburg. http://epub.uni-regensburg.de/13246/1/Dissertation_Katharina_Ruebsaamen.pdf
|
[12]
|
Xia, J., Broadhurst, D.I., Wilson, M. and Wishart, D.S. (2013) Translational Biomarker Discovery in Clinical Metabolomics: An Introductory Tutorial. Metabolomics, 9, 280-299. http://dx.doi.org/10.1007/s11306-012-0482-9
|
[13]
|
Lahiri, S. and Futerman, A.H. (2007) The Metabolism and Function of Sphingolipids and Glycosphingolipids. Cellular and Molecular Life Sciences, 64, 2270-2284. http://dx.doi.org/10.1007/s00018-007-7076-0
|
[14]
|
Ryland, L.K., Fox, T.E., Liu, X., Loughran, T.P. and Kester, M. (2011) Dysregulation of Sphingolipid Metabolism in Cancer. Cancer Biology & Therapy, 11, 138-149. http://dx.doi.org/10.4161/cbt.11.2.14624
|
[15]
|
Lv, W. and Yang, T. (2012) Identification of Possible Biomarkers for Breast Cancer from Free Fatty Acid Profiles Determined by GC-MS and Multivariate Statistical Analysis. Clinical Biochemistry, 45, 127-133. http://dx.doi.org/10.1016/j.clinbiochem.2011.10.011
|